Skip to content

Total Equity at other companies

Humana logo
HumanaHUM
$18.58B+4.7%
CVS Health logo
CVS HealthCVS
$77.46B+0.7%
Alignment Healthcare logo
Alignment HealthcareALHC
$206.89M+91.3%
Astrana Health logo
Astrana HealthASTH
$800.27M+7.4%
Elevance Health logo
Elevance HealthELV
$43.9B+3.3%
UnitedHealth Group logo
UnitedHealth GroupUNH

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.67B-49.7%
P/S1.2×-2.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clover Health Investments's total equity?
Clover Health Investments (CLOV) reported total equity of $339.43M in Q1 2026.
How has Clover Health Investments's total equity changed year-over-year?
Clover Health Investments's total equity increased by 1.0% year-over-year, from $336.08M to $339.43M.
What is the long-term trend for Clover Health Investments's total equity?
Over 5 years (2020 to 2025), Clover Health Investments's total equity has grown at a -12.9% compound annual growth rate (CAGR), from -$617.1M to $308.7M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.